Compartment syndrome in an elbw infant receiving low-molecular-weight heparins

Journal of Pediatrics

Volumn 144, Issue 4, 2004, Pages 549-

  Obaid, Laila ^a   Byrne, Paul J ^a   Cheung, Po Yin ^a  

^a ROYAL ALEXANDRA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE;

ARTICLE; CASE REPORT; CENTRAL VENOUS CATHETER; COMPARTMENT SYNDROME; DRUG SAFETY; FEMALE; HEMATOMA; HUMAN; INJECTION SITE; NEWBORN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; VERY LOW BIRTH WEIGHT;

EID: 11144357420     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2003.09.044     Document Type: Article

References (6)

1. Hausler M, Duque D, Merz U, Mertens R, Muhler E. The clinical outcome after inferior vena cava thrombosis in early infancy. Eur J Pediatr 1999;158:416-20.
2. Prandoni P, Lensing AW, Buller HR, Carta M, Cogo A, Vigo M, et al. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep vein thrombosis. Lancet 1992;339:441-5.
3. Andrew M, Michelson AD, Bovill E, Leaker M, Massicotte MP. Guidelines for antithrombotic therapy in pediatric patients. J Pediatr 1998;132:575-88.
4. Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M. low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996;128:313-23.
5. Dunaway K, Gal P, Ransom JL. Use of enoxaparin in a preterm infant. Ann Pharmacother 2000;34:1410-3.
6. Dix D, Andrew M, Marzinotto V, Charpentier K, Bridge S, Monagle P, et al. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr 2000;136:439-45.